Abdelrahim, M.; Esmail, A.; Kim, R.D.; Arora, S.P.; Arshad, J.; Kournoutas, I.A.; O’Donnell, C.D.; Totev, T.I.; Tan, A.; Mu, F.;
et al. Real-World Experiences Using Atezolizumab + Bevacizumab for the Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Study. Cancers 2025, 17, 1814.
https://doi.org/10.3390/cancers17111814
AMA Style
Abdelrahim M, Esmail A, Kim RD, Arora SP, Arshad J, Kournoutas IA, O’Donnell CD, Totev TI, Tan A, Mu F,
et al. Real-World Experiences Using Atezolizumab + Bevacizumab for the Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Study. Cancers. 2025; 17(11):1814.
https://doi.org/10.3390/cancers17111814
Chicago/Turabian Style
Abdelrahim, Maen, Abdullah Esmail, Richard D. Kim, Sukeshi Patel Arora, Junaid Arshad, Ioannis A. Kournoutas, Conor D. O’Donnell, Todor I. Totev, Amie Tan, Fan Mu,
and et al. 2025. "Real-World Experiences Using Atezolizumab + Bevacizumab for the Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Study" Cancers 17, no. 11: 1814.
https://doi.org/10.3390/cancers17111814
APA Style
Abdelrahim, M., Esmail, A., Kim, R. D., Arora, S. P., Arshad, J., Kournoutas, I. A., O’Donnell, C. D., Totev, T. I., Tan, A., Mu, F., Seshasayee, S. M., Hernandez, S., & Tran, N. H.
(2025). Real-World Experiences Using Atezolizumab + Bevacizumab for the Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Study. Cancers, 17(11), 1814.
https://doi.org/10.3390/cancers17111814
